comprehensive -WSS

comprehensive

author：knowledge 2025-10-01 15:31:32 - browse：47345

Sutter Health Palo Alto Medical Foundation facilities. health tech coverage from STAT — Adobe

When Sutter Health was on trial for anticompetitive conduct in 2022, the San Francisco jury missed out on some crucial details. They didn’t hear, for example, how its former finance chief said the system would make an extra $200 million per year by making insurers contract with all of its hospitals instead of just a few. Or how its former CEO said, “Related to the health plans, we force them to pay us more.”

That evidence was indeed relevant, and the judge erred by not allowing it to be presented during the month-long trial that concluded in March 2022, a U.S. appeals court wrote in its ruling on Tuesday. The Ninth Circuit panel overturned Sutter’s win in the class-action case alleging that Sutter used its market power to drive up health care costs across the region by more than $400 million. Tuesday’s decision means the case will likely get a second trial.

“Effectively, the appellate court said the jury was tainted,” said Matthew Cantor, lead counsel for the plaintiffs. “So the jury’s verdict is discarded.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： Letters to First Opinion on caregivers, digital health, and more

WSS

ASCO: AstraZeneca says CAR

A new drug could help frostbite victims avoid its ravages

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

Weight loss drugs aren’t covered by Obamacare. That may change

ASCO Daily Recap: Safety data from Novartis, survival from Pfizer

Medicare Advantage enrollment grows 7.1% to 33.4 million people

knowledge

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

leisure time

23andMe had bad news about my health. I wish a person had delivered it

ASCO: AstraZeneca says CAR

Medical records are filled with copy

Researchers tackle phage therapy hurdles for wider adoption

Supreme Court strikes down use of affirmative action

Ukraine seeks to reclaim its role as a hub for clinical trials

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Medicare Advantage enrollment hits roughly 33.4 million

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Abridge raises $150m as clinical notes automation market heats up

entertainment

Reporting on presidential health from Reagan to Trump and Biden

New study raises questions about niacin and heart health

Readout Newsletter: Sarepta, Alnylam, and Royalty Pharma

How to increase colonoscopy rates? Looks like an AI can help

AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

Ionis drug prevents swelling attacks due to hereditary angioedema

leisure time

focus

entertainment

hotspot